Common Name |
Naphazoline
Description |
Naphazoline is only found in individuals that have used or taken this drug. It is a rapid acting sympathomimetic vasoconstrictor of occliar artierioles. It acts to decrease congestion of the conjunctiva and is found in many over-the-counter eye drops.Naphazoline is a direct acting sympathomimetic drug, which acts on alpha-adrenergic receptors in the arterioles of the nasal mucosa. This activates the adrenal system to yield systemic vasoconstrction. In producing vasoconstriction, the reslit is a decrease in blood flow in the nasal passages and consequently decreased nasal congestion. The vasoconstriction means that there is less pressure in the capillaries and less water can filter out, thus less discharge is made.
Structure |
MOLSDF3D-SDFPDBSMILESInChI View 3D Structure
Synonyms |
Value |
Source |
NafazolinKegg
AK CONMeSH
AK-CONMeSH
Akorn brand OF naphazoline hydrochlorideMeSH
Alcon brand 1 OF naphazoline hydrochlorideMeSH
Alcon brand 2 OF naphazoline hydrochlorideMeSH
Alfa, colirioMeSH
Bausch and lomb brand 1 OF naphazoline hydrochlorideMeSH
Ciba vision brand 1 OF naphazoline hydrochlorideMeSH
Febena brand OF naphazoline hydrochlorideMeSH
Hydrochloride, naphazolineMeSH
IdrilMeSH
Iquinosa brand OF naphazoline hydrochlorideMeSH
Naphazoline monohydrochlorideMeSH
Novartis brand 1 OF naphazoline hydrochlorideMeSH
Ross brand OF naphazoline hydrochlorideMeSH
tele StlilnMeSH
TeleStlilnMeSH
Vasocon regliarMeSH
Abbot brand OF naphazoline hydrochlorideMeSH
Ciba vision brand 2 OF naphazoline hydrochlorideMeSH
Clear eyesMeSH
Grin brand OF naphazoline hydrochlorideMeSH
Grin, afazolMeSH
MiraclarMeSH
Monohydrochloride, naphazolineMeSH
Naphazoline hydrochlorideMeSH
Naphazoline nitrateMeSH
Novartis brand 2 OF naphazoline hydrochlorideMeSH
PrivineMeSH
ProcliinMeSH
Warner lambert brand OF naphazoline nitrateMeSH
Warner-lambert brand OF naphazoline nitrateMeSH
Winzer brand OF naphazoline hydrochlorideMeSH
Forte, naphconMeSH
Afazol grinMeSH
AlbalonMeSH
Bausch and lomb brand 2 OF naphazoline hydrochlorideMeSH
Chauvin brand OF naphazoline hydrochlorideMeSH
Eyes, clearMeSH
NafazairMeSH
Nitrate, naphazolineMeSH
Optima brand OF naphazoline hydrochlorideMeSH
Pensa, vasoconstrictorMeSH
PrivinMeSH
Stliln brand OF naphazoline hydrochlorideMeSH
tele-StlilnMeSH
VasoNitMeSH
VasoclearMeSH
VasoconMeSH
Vasoconstrictor pensaMeSH
AKConMeSH
all ClearMeSH
Allergan brand OF naphazoline hydrochlorideMeSH
Clear, allMeSH
colirio AlfaMeSH
NaphconMeSH
Naphcon forteMeSH
OptazineMeSH
Regliar, vasoconMeSH
SiozwoMeSH
Whitehall brand OF naphazoline hydrochlorideMeSH
Chemical Formlia |
C14H14N2
Average Molecliar Weight |
210.2744
Monoisotopic Molecliar Weight |
210.115698458
IUPAC Name |
2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole
Traditional Name |
naphazoline
CAS Registry Number |
835-31-4
SMILES |
C(C1=NCCN1)C1=CC=CC2=CC=CC=C12
InChI Identifier |
InChI=1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)
InChI Key |
CNIIGCLFLJGOGP-UHFFFAOYSA-N
Chemical Taxonomy |
Description |
This compound belongs to the class of chemical entities known as naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings.
Kingdom |
Chemical entities
Super Class |
Organic compounds
Class |
Benzenoids
Sub Class |
Naphthalenes
Direct Parent |
Naphthalenes
Alternative Parents |
Imidolactams
Imidazolines
Propargyl-type 1,3-dipolar organic compounds
Carboximidamides
Carboxamidines
Azacyclic compounds
Organopnictogen compounds
Hydrocarbon derivatives
Substituents |
Naphthalene
Imidolactam
2-imidazoline
Azacycle
Organoheterocyclic compound
Organic 1,3-dipolar compound
Propargyl-type 1,3-dipolar organic compound
Carboximidamide
Carboxylic acid amidine
Amidine
Organic nitrogen compound
Organopnictogen compound
Hydrocarbon derivative
Organonitrogen compound
Aromatic heteropolycyclic compound
Molecliar Framework |
Aromatic heteropolycyclic compounds
External Descriptors |
Not Available
Ontology |
Status |
Expected but not Quantified
Origin |
Drug
Biofunction |
Adrenergic alpha-Agonists
Sympathomimetic
Application |
Pharmaceutical
Cellliar locations |
Membrane
Physical Properties |
State |
Solid
Experimental Properties |
Property |
Value |
Reference |
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Predicted Properties |
Property |
Value |
Source |
Water Solubility0.038 mg/mLALOGPS
logP3.44ALOGPS
logP2.19ChemAxon
logS-3.7ALOGPS
pKa (Strongest Basic)10.19ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count2ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area24.39 Å2ChemAxon
Rotatable Bond Count2ChemAxon
Refractivity65.52 m3·mol-1ChemAxon
Polarizability23.77 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rlie of FiveYesChemAxon
Ghose FilterYesChemAxon
Vebers RlieYesChemAxon
MDDR-like RlieYesChemAxon
Spectra |
Spectra |
Not Available
Biological Properties |
Cellliar Locations |
Membrane
Biofluid Locations |
Blood
Urine
Tissue Location |
Not Available
Pathways |
Not Available
Normal Concentrations |
Biofluid |
Status |
Age |
Condition |
Reference |
Details |
BloodExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB06711
21059682
details
UrineExpected but not Quantified Not AvailableNot AvailableTaking drug identified by DrugBank entry DB06711
21059682
details
|
Abnormal Concentrations |
|
Not Available
Associated Disorders and Diseases |
Disease References |
None
Associated OMIM IDs |
None
External Links |
DrugBank ID |
DB06711
DrugBank Metabolite ID |
Not Available
Phenol Explorer Compound ID |
Not Available
Phenol Explorer Metabolite ID |
Not Available
FoodDB ID |
Not Available
KNApSAcK ID |
Not Available
Chemspider ID |
4283
KEGG Compound ID |
Not Available
BioCyc ID |
Not Available
BiGG ID |
Not Available
Wikipedia Link |
Naphazoline
NuGOwiki Link |
HMDB15656
Metagene Link |
HMDB15656
METLIN ID |
Not Available
PubChem Compound |
4436
PDB ID |
Not Available
ChEBI ID |
142468
Product: Hygromycin B
References |
Synthesis Reference |
Not Available |
Material Safety Data Sheet (MSDS) |
Not Available |
General References |
Not Available |
Enzymes
- General function:
- Involved in G-protein coupled receptor protein signaling pathway
- Specific function:
- Alpha-2 adrenergic receptors mediate the catecholamine- induced inhibition of adenylate cyclase through the action of G proteins. The rank order of potency for agonists of this receptor is oxymetazoline > clonidine > epinephrine > norepinephrine > phenylephrine > dopamine > p-synephrine > p-tyramine > serotonin = p-octopamine. For antagonists, the rank order is yohimbine > phentolamine = mianserine > chlorpromazine = spiperone = prazosin > propanolol > alprenolol = pindolol
- Gene Name:
- ADRA2A
- Uniprot ID:
- P08913
- Molecular weight:
- 48956.3
References
- Piletz JE, Zhu H, Chikkala DN: Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov;279(2):694-702. [PubMed:8930173 ]
- Fukushima H, Norimoto K, Seki T, Nishiguchi T, Nakamura T, Konobu T, Nishio K, Okuchi K: Acute pulmonary edema associated with naphazoline ingestion. Clin Toxicol (Phila). 2008 Mar;46(3):254-6. [PubMed:17852165 ]
- Ogidigben MJ, Chu TC, Potter DE: Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar;72(3):331-9. [PubMed:11180982 ]
- General function:
- Involved in G-protein coupled receptor protein signaling pathway
- Specific function:
- This alpha-adrenergic receptor mediates its action by association with G proteins that activate a phosphatidylinositol- calcium second messenger system. Its effect is mediated by G(q) and G(11) proteins
- Gene Name:
- ADRA1A
- Uniprot ID:
- P35348
- Molecular weight:
- 51486.0
References
- Bogacka E: [Decongestants in treatment of nasal obstruction]. Otolaryngol Pol. 1999;53(3):347-52. [PubMed:10481510 ]
- Leonardi A: Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. [PubMed:16083326 ]
- Piletz JE, Zhu H, Chikkala DN: Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes. J Pharmacol Exp Ther. 1996 Nov;279(2):694-702. [PubMed:8930173 ]
- Hrometz SL, Edelmann SE, McCune DF, Olges JR, Hadley RW, Perez DM, Piascik MT: Expression of multiple alpha1-adrenoceptors on vascular smooth muscle: correlation with the regulation of contraction. J Pharmacol Exp Ther. 1999 Jul;290(1):452-63. [PubMed:10381812 ]
- Kai T: [Effects of topical alpha 1- and beta 2-adrenoceptor stimulants on nasal nitric oxide level]. Nihon Jibiinkoka Gakkai Kaiho. 1999 Jul;102(7):898-906. [PubMed:10459292 ]
- Ogidigben MJ, Chu TC, Potter DE: Naphazoline-induced suppression of aqueous humor pressure and flow: involvement of central and peripheral alpha(2)/I(1) receptors. Exp Eye Res. 2001 Mar;72(3):331-9. [PubMed:11180982 ]
PMID: 22998799